| Title： | Evidence-based clinical practice guideline for Management of Attention Deficit Hyperactivity Disorder (ADHD) in Saudi Arabia |
| Edition： | Adapted |
| Classification： | Standard guideline |
| Field： | Comprehensive guideline |
| Countries and regions： | Saudi Arabia |
| Guidelines users： | Physicians, Clinical psychologists, Other behavioral health clinicians, Nurses, Occupational therapists, Pharmacists, Social workers, Dietitians, Medical students, and Medical sciences students |
| Evidence classification method： | The 'King Saud University (KSU) Modified ADAPTE' Method was used, as a formal adaptation framework, in the synthesis of this national evidence-based clinical practice guideline (CPG). Quality assessment or critical appraisal of the eligible source original CPGs was conducted using the Appraisal of Guidelines for Research and Evaluation (AGREE) II Instrument (https://doi.org/10.1371/journal.pone.0219239). We have used the same rating system for the hierarchy of evidence and strength of recommendation that was proposed by the final high-quality source CPG that was selected based on this AGREE II assessment. |
| Development unit： | Saudi ADHD Society |
| Registration time: | 2021-11-22 |
| Registration number： | IPGRP-2021CN379 |
| Purpose of the guideline: | This adapted CPG is intended for use by healthcare professionals to aid in the evidence-based management of ADHD in children under 5 years, children and young people (aged 5 to 17 years), and adults aged 18 years or over. |
Latest registration
